| Neuropharmacology of new psychoactive substances (NPS): focus on the rewarding and reinforcing properties of cannabimimetics and amphetamine-like stimulants C Miliano, G Serpelloni, C Rimondo, M Mereu, M Marti, MA De Luca Frontiers in neuroscience 10, 175369, 2016 | 182 | 2016 |
| R-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse CJ Loland, M Mereu, OM Okunola, J Cao, TE Prisinzano, S Mazier, ... Biological psychiatry 72 (5), 405-413, 2012 | 149 | 2012 |
| The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders M Mereu, A Bonci, AH Newman, G Tanda Psychopharmacology 229, 415-434, 2013 | 146 | 2013 |
| Sigma receptor agonists: receptor binding and effects on mesolimbic dopamine neurotransmission assessed by microdialysis L Garcés-Ramírez, JL Green, T Hiranita, TA Kopajtic, M Mereu, ... Biological psychiatry 69 (3), 208-217, 2011 | 97 | 2011 |
| Genetic disruption of Arc/Arg3. 1 in mice causes alterations in dopamine and neurobehavioral phenotypes related to schizophrenia F Manago, M Mereu, S Mastwal, R Mastrogiacomo, D Scheggia, ... Cell reports 16 (8), 2116-2128, 2016 | 89 | 2016 |
| Brain-wide mapping of endogenous serotonergic transmission via chemogenetic fMRI A Giorgi, S Migliarini, A Galbusera, G Maddaloni, M Mereu, G Margiani, ... Cell reports 21 (4), 910-918, 2017 | 85 | 2017 |
| Acetaldehyde sequestering prevents ethanol-induced stimulation of mesolimbic dopamine transmission P Enrico, D Sirca, M Mereu, AT Peana, A Lintas, A Golosio, M Diana Drug and alcohol dependence 100 (3), 265-271, 2009 | 71 | 2009 |
| Dopamine transporter (DAT) genetic hypofunction in mice produces alterations consistent with ADHD but not schizophrenia or bipolar disorder M Mereu, G Contarini, EF Buonaguro, G Latte, F Managò, F Iasevoli, ... Neuropharmacology 121, 179-194, 2017 | 57 | 2017 |
| SINEUP non-coding RNA targeting GDNF rescues motor deficits and neurodegeneration in a mouse model of Parkinson’s disease S Espinoza, M Scarpato, D Damiani, F Managò, M Mereu, A Contestabile, ... Molecular Therapy 28 (2), 642-652, 2020 | 56 | 2020 |
| Lack of specific involvement of (+)-naloxone and (+)-naltrexone on the reinforcing and neurochemical effects of cocaine and opioids G Tanda, M Mereu, T Hiranita, JC Quarterman, M Coggiano, JL Katz Neuropsychopharmacology 41 (11), 2772-2781, 2016 | 54 | 2016 |
| Cocaine‐induced endocannabinoid release modulates behavioral and neurochemical sensitization in mice M Mereu, V Tronci, LE Chun, AM Thomas, JL Green, JL Katz, G Tanda Addiction biology 20 (1), 91-103, 2015 | 52 | 2015 |
| Antioxidants, minerals, vitamins, and herbal remedies in tinnitus therapy P Enrico, D Sirca, M Mereu Progress in brain research 166, 323-330, 2007 | 52 | 2007 |
| Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment D Scheggia, R Mastrogiacomo, M Mereu, S Sannino, RE Straub, ... Nature communications 9 (1), 2265, 2018 | 48 | 2018 |
| Preference for distinct functional conformations of the dopamine transporter alters the relationship between subjective effects of cocaine and stimulation of mesolimbic dopamine SJ Kohut, T Hiranita, SK Hong, AL Ebbs, V Tronci, J Green, ... Biological psychiatry 76 (10), 802-809, 2014 | 45 | 2014 |
| Serotonergic signaling controls input-specific synaptic plasticity at striatal circuits A Cavaccini, M Gritti, A Giorgi, A Locarno, N Heck, S Migliarini, A Bertero, ... Neuron 98 (4), 801-816. e7, 2018 | 43 | 2018 |
| L-cysteine reduces oral ethanol self-administration and reinstatement of ethanol-drinking behavior in rats AT Peana, G Muggironi, G Calvisi, P Enrico, M Mereu, M Nieddu, G Boatto, ... Pharmacology Biochemistry and Behavior 94 (3), 431-437, 2010 | 42 | 2010 |
| Synthetic cannabinoids: the hidden side of Spice drugs N Pintori, B Loi, M Mereu Behavioural pharmacology 28 (6), 409-419, 2017 | 41 | 2017 |
| Self-administration of cocaine induces dopamine-independent self-administration of sigma agonists T Hiranita, M Mereu, PL Soto, G Tanda, JL Katz Neuropsychopharmacology 38 (4), 605-615, 2013 | 41 | 2013 |
| The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans GM Leggio, SA Torrisi, R Mastrogiacomo, D Mauro, M Chisari, C Devroye, ... Molecular psychiatry 26 (4), 1272-1285, 2021 | 40 | 2021 |
| The unique psychostimulant profile of (±)‐modafinil: investigation of behavioral and neurochemical effects in mice M Mereu, LE Chun, TE Prisinzano, AH Newman, JL Katz, G Tanda European journal of neuroscience 45 (1), 167-174, 2017 | 37 | 2017 |
